Research Article
Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
Figure 1
Oral administration of AcSDKP increased the plasma and urine levels of AcSDKP. 8-week-old CD-1 mice were provided single administration of the indicated amount of AcSDKP by oral gavage using a cannula. Two hours after the administration of AcSDKP, the mice were euthanized. (a) Plasma and (b) urine levels of AcSDKP were evaluated by commercially available ELISA kits. in each group.
(a) |
(b) |